TTM
$2.98B
YoY change
+14.7%
5Y CAGR
+16.9%
Peak year (2025)
$2.80B
Cumulative gross profit
$16.22B
Gross Profit history chart for DexCom (DXCM) from 2000 to 2025
Latest: $2.80B
Gross Profit growth chart for DexCom (DXCM) from 2000 to 2025
Latest: +14.7%
Gross Profit history table for DexCom (DXCM) from 2000 to 2025
| 2025 | $2.80B | +14.7% | +$359.50M | ||
| 2024 | $2.44B | +6.5% | +$149.30M | ||
| 2023 | $2.29B | +21.5% | +$405.80M | ||
| 2022 | $1.88B | +12.1% | +$202.60M | ||
| 2021 | $1.68B | +31.3% | +$400.40M | ||
| 2020 | $1.28B | +37.4% | +$348.60M | ||
| 2019 | $931.50M | +40.3% | +$267.60M | ||
| 2018 | $663.90M | +34.9% | +$171.80M | ||
| 2017 | $492.10M | +30.0% | +$113.70M | ||
| 2016 | $378.40M | +35.9% | +$100.00M | ||
| 2015 | $278.40M | +57.9% | +$102.10M | ||
| 2014 | $176.30M | +76.1% | +$76.20M | ||
| 2013 | $100.10M | +114.8% | +$53.50M | ||
| 2012 | $46.60M | +30.0% | +$10.76M | ||
| 2011 | $35.84M | +94.4% | +$17.40M | ||
| 2010 | $18.44M | +403.8% | +$14.78M | ||
| 2009 | $3.66M | -166.2% | +$9.19M | ||
| 2008 | −$5.53M | -31.8% | +$2.58M | ||
| 2007 | −$8.11M | -7.7% | +$680.16K | ||
| 2006 | −$8.79M | — | −$8.79M | ||
| 2005 | $0.00 | — | $0.00 | ||
| 2004 | $0.00 | — | $0.00 | ||
| 2003 | $0.00 | — | $0.00 | ||
| 2002 | $0.00 | — | $0.00 | ||
| 2001 | $0.00 | — | $0.00 | ||
| 2000 | $0.00 | — | — |
- 2025$2.80B+14.7%
- 2024$2.44B+6.5%
- 2023$2.29B+21.5%
- 2022$1.88B+12.1%
- 2021$1.68B+31.3%
- 2020$1.28B+37.4%
- 2019$931.50M+40.3%
- 2018$663.90M+34.9%
- 2017$492.10M+30.0%
- 2016$378.40M+35.9%
- 2015$278.40M+57.9%
- 2014$176.30M+76.1%
- 2013$100.10M+114.8%
- 2012$46.60M+30.0%
- 2011$35.84M+94.4%
- 2010$18.44M+403.8%
- 2009$3.66M-166.2%
- 2008−$5.53M-31.8%
- 2007−$8.11M-7.7%
- 2006−$8.79M—
- 2005$0.00—
- 2004$0.00—
- 2003$0.00—
- 2002$0.00—
- 2001$0.00—
- 2000$0.00—
Gross Profit values are taken from DexCom's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Gross Profit at DexCom (DXCM)
According to DexCom's latest reported financial statements, the company's current gross profit (TTM) is $2.98B. Gross profit equals revenue minus the cost of goods sold (COGS) — what remains from sales after the direct cost of producing the product or service. It does not yet subtract operating expenses, interest, or taxes (see operating income and net income for those steps). Higher gross profit (and gross margin) generally signals pricing power and production efficiency.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
2025's annual gross profit for DexCom (DXCM) came in at $2.80B – grew 14.7% year-over-year.
DexCom gross profit compound annual growth for the 2020–2025 (5 years) window is +16.9%, sustaining 19 straight years of year-over-year growth.
The record annual gross profit stands at $2.80B, reached in 2025; the historical low of −$8.79M was recorded in 2006.
DexCom Gross Profit by Year
DexCom Gross Profit 2025: $2.80B
DexCom gross profit in 2025 was $2.80B, grew 14.7% from 2024. This figure represents the highest annual value in the available history.
DexCom Gross Profit 2024: $2.44B
2024's gross profit for DexCom came in at $2.44B, grew 6.5% from 2023.
DexCom Gross Profit 2023: $2.29B
DexCom posted gross profit of $2.29B in 2023, grew 21.5% from 2022.
DexCom Gross Profit 2022: $1.88B
In 2022, DexCom reported gross profit of $1.88B, grew 12.1% from 2021.
DexCom Gross Profit 2021: $1.68B
DexCom gross profit in 2021 was $1.68B.
See more financial history for DexCom (DXCM).
Sector peers by Gross Profit
Healthcare peers of DexCom (DXCM), ranked by their latest gross profit
| $82.92B | |
| $68.56B | |
| $54.62B | |
| $48.11B | |
| $46.73B | |
| $42.96B | |
| $39.01B | |
| $26.01B |
- $82.92B
- $68.56B
- $54.62B
- $48.11B
- $46.73B
- $42.96B
- $39.01B
- $26.01B
Frequently asked questions
DexCom (DXCM) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation